In cancers such as embryonic rhabdomyosarcoma (ERMS), HMGA2 upregulates IMP2, stabilizing NRAS mRNA and sustaining oncogenic NRAS signaling. The gene discussed is IGF2BP2; the disease is embryonal rhabdomyosarcoma.